Dorian Therapeutics Investors
Developer of novel therapeutics designed to rejuvenate cells and tissues. The company's therapeutics inhibit the ex vivo aging process and rejuvenate T cells increasing their function, fitness, and persistence, enabling medical practitioners to reactivate programs of youthfulness and Therapeutics 2025 : Valuation, Funding ...?
Headquarters:
United States, San Carlos
Employee Number:
1-10
Number Of Exists:
Seed
Founded Date:
2018